Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/CELLDEX-THERAPEUTICS-INC-4067392/news/Celldex-Therapeutics-Initiates-Phase-1-2-Study-of-Varlilumab-in-Combination-with-Sunitinib-in-Metast-20451751/?utm_source=whatsapp&utm_medium=social&utm_campaign=share